Srs Capital Advisors, Inc. Zynerba Pharmaceuticals, Inc. Transaction History

Srs Capital Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	BUY	$0.86 - $2.06 $1,417 - $3,394	1,648 Added 32.96%	6,648 $8,000
Q1 2022 May 12, 2022	BUY	$1.83 - $3.02 $4,575 - $7,550	2,500 Added 100.0%	5,000 $10,000
Q3 2021 Nov 05, 2021	BUY	$3.72 - $5.35 $9,300 - $13,375	2,500 New	2,500 $11,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Srs Capital Advisors, Inc. with notifications on news.